Supernus Pharmaceuticals Inc (SUPN)
Operating Expenses
$243.35M
Quarterly · Period ending: · USD
SUPN Operating Expenses
Latest reported$243.35Mperiod ending
Latest reported$243.35Mperiod ending
SUPN Quarterly Operating Expenses ($8.60M → $243.35M)
Quarterly operating expenses
High-resolution chart · PNG
SUPN operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 243,352,000 | |
| 192,646,000 | |
| 174,743,000 | |
| 233,369,000 | |
| 136,485,000 | |
| 144,317,000 | |
| 126,656,000 | |
| 117,261,000 | |
| 127,840,000 | |
| 130,488,000 | |
| 145,683,000 | |
| 126,141,000 | |
| 132,059,000 | |
| 125,128,000 | |
| 110,040,000 | |
| 152,998,000 | |
| 138,248,000 | |
| 132,607,000 | |
| 135,958,000 | |
| 97,775,000 | |
| 82,188,000 | |
| 102,764,000 | |
| 82,026,000 | |
| 77,607,000 | |
| 72,795,000 | |
| 61,812,000 | |
| 55,517,000 | |
| 57,592,000 | |
| 58,053,000 | |
| 56,362,000 | |
| 71,891,000 | |
| 61,314,000 | |
| 60,135,000 | |
| 55,757,000 | |
| 49,937,000 | |
| 53,805,000 | |
| 45,901,000 | |
| 37,839,000 | |
| 42,307,000 | |
| 33,543,000 | |
| 37,230,000 | |
| 35,722,000 | |
| 33,012,000 | |
| 32,029,000 | |
| 30,214,000 | |
| 23,085,000 | |
| 23,790,000 | |
| 22,000,000 | |
| 24,258,000 | |
| 22,009,000 | |
| 20,625,000 | |
| 18,399,000 | |
| 15,756,000 | |
| 18,055,000 | |
| 13,834,000 | |
| 12,381,000 | |
| 9,348,000 | |
| 8,086,000 | |
| 10,285,000 | |
| 9,926,000 | |
| 9,146,000 | |
| 9,198,000 | |
| 10,760,530 | |
| 8,602,343 |